{"organizations": [], "uuid": "e59f9e11b0341271046dc9063ff8a832dc93d7b8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180510.html", "section_title": "Archive News &amp; Video for Thursday, 10 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-kala-pharmaceuticals-reports-q1-lo/brief-kala-pharmaceuticals-reports-q1-loss-per-share-of-0-46-idUSASC0A1CA", "country": "US", "domain_rank": 408, "title": "BRIEF-Kala Pharmaceuticals Reports Q1 Loss Per Share Of $0.46", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-10T19:13:00.000+03:00", "replies_count": 0, "uuid": "e59f9e11b0341271046dc9063ff8a832dc93d7b8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-kala-pharmaceuticals-reports-q1-lo/brief-kala-pharmaceuticals-reports-q1-loss-per-share-of-0-46-idUSASC0A1CA", "ord_in_thread": 0, "title": "BRIEF-Kala Pharmaceuticals Reports Q1 Loss Per Share Of $0.46", "locations": [], "entities": {"persons": [{"name": "finan", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters) - kala pharmaceuticals inc", "sentiment": "neutral"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "cial", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 10 (Reuters) - Kala Pharmaceuticals Inc:\n* KALA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.46 * Q1 EARNINGS PER SHARE VIEW $-0.45 â€” THOMSON REUTERS I/B/E/S\n* AS OF MARCH 31, 2018, HAD CASH OF $100.5 MILLION COMPARED TO $114.6 MILLION AS OF DECEMBER 31, 2017\n* ANTICIPATES THAT ITS EXISTING CASH ON HAND WILL ENABLE IT TO FUND OPERATIONS THROUGH AT LEAST NEXT TWELVE MONTHS Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-10T19:13:00.000+03:00", "crawled": "2018-05-11T12:54:25.007+03:00", "highlightTitle": ""}